Binding of antigen to the B cell antigen receptor (BCR) triggers both BCR signaling and endocytosis. How endocytosis regulates BCR signaling remains unknown. Here we report that BCR signaling was not extinguished by endocytosis of BCRs; instead, BCR signaling initiated at the plasma membrane continued as the BCR trafficked intracellularly with the sequential phosphorylation of kinases. Blocking the endocytosis of BCRs resulted in the recruitment of both proximal and downstream kinases to the plasma membrane, where mitogen-activated protein kinases (MAPKs) were hyperphosphorylated and the kinase Akt and its downstream target Foxo were hypophosphorylated, which led to the dysregulation of gene transcription controlled by these pathways. Thus, the cellular location of the BCR serves to compartmentalize kinase activation to regulate the outcome of signaling.
The binding of antigen to the B cell antigen receptor (BCR) results in the assembly of a multicomponent signaling complex that ultimately triggers the transcription of a variety of genes through the activation of at least four major signaling pathways, including the mitogenactivated protein kinase (MAPK) and kinase Akt signaling pathways 1 . Binding of antigen also triggers the endocytosis of the BCR and its trafficking to specialized intracellular compartments in which antigen processing occurs 2 . Many of the components of the BCR signaling pathway and their interactions have been described, and the trafficking of the BCR into antigen-processing compartments has been mapped out in some detail. However, the temporal and spatial relationship between the endocytosis of the BCR and the assembly of active signaling complexes and whether such endocytosis has a role in determining the outcome of signaling remain unknown.
The BCR is composed of a membrane form of immunoglobulin noncovalently associated with a disulfide-linked heterodimer of two integral membrane proteins, CD79a and CD79b 3 . These chains have in their cytoplasmic domains immunoreceptor tyrosine activation motifs that are phosphorylated by tyrosine kinases of the Src family after antigen binding, which results in the activation and recruitment of the tyrosine kinase Syk 4, 5 . These early events trigger the phosphorylation of many downstream substrates, including adaptors that are necessary for the activation of key effector enzymes 6 . Once activated, the effector enzymes generate small-molecule second messengers that activate additional effector enzymes to amplify the signal from the BCR, which ultimately triggers the transcription of genes associated with B cell activation. The temporal regulation of the activation of many components of the BCR signaling pathways has been described; however, where in the B cell these signaling events occur and whether the location of the BCR influences the outcome of signaling are not known.
Results from a variety of studies have established that the internalization and proper trafficking of the BCR into antigen-processing compartments requires BCR signaling 7 . Through the use of a combination of mice deficient in various components of the BCR signaling pathway and inhibitors of BCR signaling components, studies have provided evidence that many tyrosine kinases, adaptors and effector enzymes are required for internalization of the BCR and for efficient antigen processing and presentation [8] [9] [10] [11] [12] [13] [14] [15] . Collectively, such studies have highlighted the importance of BCR signaling in triggering the internalization and trafficking of the BCR. However, it is not known whether the endocytosed BCR continues to actively signal and if the intracellular location of the BCR influences the quality of the transmitted signal. In fact, internalization of the BCR has been suggested to function to extinguish active signaling 16 .
The endosomal system, once regarded as a simple pathway for the degradation or recycling of internalized cell-surface receptors, is now widely recognized as an essential site of signal transduction for many receptors 17, 18 . Two well-studied receptors, epidermal growth factor receptor and the nerve growth factor receptor TrKA, initiate signaling at the cell surface and continue to signal in endosomes after internalization 19, 20 . For these receptors, optimum signaling is achieved only after internalization. Indeed, many components that regulate signaling are present only on endosomes 21 . It has also been shown that the signals transmitted from endosomes are distinct from those that emanate from the cell surface. TrKA activates the GTPase Ras pathway transiently at the plasma membrane, whereas once it is internalized into endosomes, TrKA induces sustained Mitogen activated protein kinase MAPK activation 22 . In addition, in cells of the immune response, Toll-like receptor 4 (TLR4) has been shown to activate two different signaling pathways sequentially, first inducing TIRAPMyD88 signaling at the plasma membrane and then, after endocytosis, activating TRAM-TRIF signaling from early endosomes 23 . So far, intracellular signaling by the BCR has not been described, and it is not clear if full BCR signaling also requires endocytosis.
Here we show that BCR signaling was initiated at the plasma membrane with the recruitment and phosphorylation of the early proximal kinases Lyn and Syk. This signaling continued after the BCR was endocytosed and trafficked through early endosomes positive for the transferrin receptor (TfR) to late endosomes and multivesicular compartments positive for the lysosomal marker LAMP-1, with the recruitment and phosphorylation of downstream kinases, initially c-Raf and subsequently the MAPKs Erk, p38 and Jnk. Blocking BCR internalization with a highly specific inhibitor of endocytosis resulted in the recruitment of both proximal and downstream kinases to the plasma membrane where kinase phosphorylation was dysregulated, which led to hyperphosphorylation of MAPKs and hypophosphorylation of Akt and its downstream target Foxo and dysregulation of gene transcription. Our data present a new view of the control of the outcome of BCR signaling in which endocytosis does not function to extinguish signaling but instead serves to regulate kinase phosphorylation to appropriately activate target gene transcription.
RESULTS

Temporal and spatial patterns of kinase activation
We first used transmission electron microscopy (TEM) to obtain a high-resolution map of antigen-induced internalization of the BCR. For this, we incubated mouse splenic B cells for various lengths of time with rat antibody to mouse immunoglobulin M (IgM) conjugated to electron-dense magnetic beads (to crosslink BCRs), then fixed and imaged the cells. At time 0, BCRs were distributed over the plasma membrane (Fig. 1a) . Within 2 min of crosslinking, BCRs were present both in coated pits at the cell surface and in early endosomes immediately under the plasma membrane ranging in diameter from 50 nm to 100 nm. By 10 min, most BCRs were internalized and were present in both early and larger late endosomes. By 20-45 min after crosslinking, the internalized BCRs had accumulated intracellularly in large multivesicular compartments approximately 200-500 nm in diameter (Fig. 1a) .
To determine when and where various kinases in the BCR signaling cascades were phosphorylated, we either left mouse splenic B cells untreated or incubated them for various lengths of time (up to 30 min) at 37 °C with indodicarbocyanine-conjugated F(ab′) 2 goat antibody to mouse IgM (Cy5-anti-IgM) to both label and crosslink the BCRs. We fixed and made the cells permeable and stained them with primary antibodies specific for phosphorylated Lyn (p-Lyn), as a marker for a kinase activated early in the BCR signaling pathway (however, the antibody recognizes phosphorylation at Tyr507 and is thus specific for inactive phosphorylated Lyn); phosphorylated c-Raf (p-c-Raf), an intermediate kinase; or phosphorylated Jnk (p-Jnk), a kinase activated late in the pathway. We detected primary antibodies with Alexa Fluor 488-conjugated secondary antibodies and analyzed cells by confocal microscopy (Fig. 1b) . We quantified the fluorescence intensity of Cy5 and Alexa Fluor 488 for each image. In addition, at each time point we calculated the Pearson's colocalization coefficient for the phosphorylated kinases and the BCR (Fig. 2) . Before the addition of the Cy5-anti-IgM at 0 min, there was little detectable p-Lyn, p-c-Raf or p-Jnk in the B cells. At 30 s after BCR crosslinking, p-Lyn was first detectable, and it localized together with the BCR at the plasma membrane. Within 2 min, p-Lyn and the BCR seemed to be present in structures with a more punctuate appearance, possibly vesicles that appeared inside the cell just under the plasma membrane. At 5 min, a portion of p-Lyn continued to localize together with the BCR at the plasma membrane and with the internalized BCR. By 30 min, the p-Lyn signal was much lower and was nearly undetectable, whereas most of the BCR that was inside the cell in large multivesicular compartments, as observed by TEM (Fig. 1a) , did not localize together with p-Lyn (Figs. 1b and 2) .
We observed a different pattern for p-c-Raf. In most cells, we initially detected p-c-Raf later than p-Lyn, approximately 2 min after BCR crosslinking, and p-c-Raf localized together with the BCR at the plasma membrane and possibly in vesicles underneath the plasma membrane (Figs. 1b and 2). At 15 min, p-c-Raf continued to accumulate inside the cell and to localize together with the BCR. By 30 min, the p-c-Raf signal was much lower, but the remaining signal was localized together with the internalized BCR, observed by TEM to be in late endosomes and multivesicular compartments (Fig. 1a) . Thus, p-c-Raf appeared later in the BCR trafficking pathway than did p-Lyn and accumulated in intracellular compartments in which p-Lyn was not present. Phosphorylated forms of Erk (p-Erk), a kinase directly downstream of c-Raf, also first appeared at approximately 2 min after BCR crosslinking at the plasma membrane and in vesicles inside the cell underneath the membrane and localized together with the BCR ( Fig. 2 and Supplementary Fig. 1 ). At 15 min, p-Erk also continued to accumulate inside the cell and localized together with the BCR, but unlike p-c-Raf, p-Erk did not decrease over time, and at 30 min it remained localized together with the BCR. We observed a still different pattern for p-Jnk. We first detected a small amount of p-Jnk approximately 5 min after BCR crosslinking; it localized together with the BCR in intracellular vesicles (Figs. 1b and 2 ). This p-Jnk persisted and remained associated with internalized BCR for 30 min, when we observed the internalized BCR by TEM in late endosomes and multivesicular compartments (Fig. 1a) . We noted a similar pattern for phosphorylated p38 (p-p38); it localized together with the BCR almost exclusively in large multivesicular bodies 30 min after BCR crosslinking ( Fig. 2 and Supplementary Fig. 1 ).
We further characterized the subcellular compartments in which phosphorylated kinases were localized together with the BCRs. We incubated cells for various times with anti-IgM, made them permeable and stained them with antibodies specific for phosphorylated kinases followed by Alexa Fluor 647-labeled secondary antibodies, plus anti-TfR (to mark early endosomes) or anti-LAMP-1 (to mark late endosomal and multivesicular compartments followed by Alexa Fluor 488-labeled secondary antibodies.). We merged the confocal images and quantified the intensity of the staining of phosphorylated kinases and BCRs across the cells (Fig. 3a) . We also determined Pearson's colocalization coefficients for phosphorylated kinases and the BCRs (Fig. 3b) . Most BCRs localized together with TfR + vesicles 5-7 min after crosslinking, and at 15 min, BCRs were concentrated in LAMP-1 + compartments (data not shown). At 7 min after BCR crosslinking, most internalized p-Lyn was in TfR + vesicles but not in LAMP-1 + vesicles (Fig. 3) . Analysis of phosphorylated Syk (p-Syk) showed a pattern similar to that of p-Lyn. By 15 min, when the BCR had trafficked to LAMP-1 + compartments, p-Lyn and p-Syk were nearly undetectable (data not shown). At 7 min after BCR crosslinking, both p-c-Raf and p-Erk were detectable in TfR + endosomes (Fig. 3) . By 15 min, only a portion of p-c-Raf was localized together with LAMP-1, but most p-Erk was concentrated in LAMP-1 + compartments (Fig. 3a,b) . We observed a pattern similar to that of p-Erk for p-p38 and p-Jnk: p-Erk, p-p38 and p-Jnk continued to be localized together with the BCR in LAMP-1 + compartments even 45 min after BCR crosslinking (Supplementary Fig. 1 ). 
A r t i c l e s
We used TEM to obtain images of higher resolution of the subcellular location of phosphorylated kinases (Fig. 4) . We treated cells for various times up to 45 min with anti-IgM, then fixed and made the cells permeable and them incubated them with antibodies specific for p-Syk, p-Erk, p-p38 and p-Jnk, followed by staining with horseradish peroxidase-labeled secondary antibodies and development with 3, 3-diaminobenzidine tetrahydrochloride. Phosphorylated kinases were not detectable in unstimulated cells (0 min). Within 3 min of BCR crosslinking, p-Syk was detectable at the plasma membrane and just beneath the plasma membrane in small vesicles approximately 50-100 nm in diameter. By 10 min, most p-Syk was detectable in intracellular vesicles. By 20 min, most cells had no p-Syk. In the few cells in which p-Syk was detectable at 20 min, p-Syk was present in large late endosomes and not in multivesicular compartments. In contrast, p-Erk, p-p38 and p-Jnk were detectable exclusively in intra-
Collectively, the data reported above indicated distinct temporal and spatial patterns of kinase phosphorylation in the BCR signaling pathway. After crosslinking, the BCR first associated with p-Lyn and p-Syk and, minutes later, associated with p-c-Raf and p-Erk at the plasma membrane. As the BCR trafficked into the cell into early endosomes, p-Lyn, p-Syk remained associated with the BCR in TfR + vesicles, p-c-Raf and p-Erk continued to accumulate, and p-p38 and p-Jnk appeared. As the BCR moved from TfR + vesicles into LAMP-1 + compartments, p-Lyn and p-Syk were no longer detectable, there was less BCR-associated p-c-Raf, and BCR-associated p-Jnk, p-Erk and p-p38 continued to accumulate in multivesicular compartments (Supplementary Fig. 2 ).
The actin cytoskeleton in kinase activation
To determine if the spatial pattern of the phosphorylation of kinases noted above was dependent on the actin cytoskeleton, we incubated cells with Cy5-anti-IgM in the presence or absence of latrunculin A, which disrupts filaments of the actin cytoskeleton by preventing the polymerization of F-actin (Supplementary Fig. 3) . We made cells permeable and immunostained them to detect p-Lyn, p-Syk, p-c-Raf, p-Erk, p-p38 or p-Jnk by confocal microscopy. In cells treated with latrunculin A, the BCR failed to internalize and remained at the cell surface. However, both proximal and downstream kinases were phosphorylated and localized together with the BCR at the plasma membrane; this mislocalization included Erk, p38 and Jnk that in untreated cells were mainly phosphorylated in LAMP-1 + intracellular compartments (Supplementary Fig. 3) . Thus, disruption of the actin cytoskeleton disrupted the spatial distribution of kinase phosphorylation.
Blocking endocytosis dysregulates kinase activation
Internalization of BCR-antigen complexes has been shown to occur via a clathrin-and dynamin-dependent pathway 15, 24 . Dynasore is a small-molecule inhibitor that reversibly and selectively inhibits dynamin 1 and 2, which are required for clatherin-mediated endocytosis, and the mitochondrial dynamin Srp1 (Drp1), but not other small GTPases 25 . We first assessed by TEM the effect of dynasore on the internalization of BCRs. We left cells untreated or treated them with dynasore, then incubated them for 15 min on ice with anti-mouse IgM conjugated to electron-dense magnetic beads, followed by incubation for up to 45 min at 37 °C, then fixed and imaged the cells (Fig. 5a,b) . Treatment of cells with dynasore seemed to block BCR internalization completely and reversibly (data not shown), and the BCR remained on the surface throughout the entire 45-minute time course. We also quantified the effect of dynasore on BCR internalization over time by flow cytometry measuring the amount of biotinylated anti-IgM on the surface with fluorescence-conjugated streptavidin.
In untreated cells, approximately 70% of the BCR was internalized by 30 min, and this internalization was blocked nearly completely by treatment with dynasore (Fig. 5c) . Collectively, these results confirmed the dependence of BCR internalization on dynamin.
To determine the effect of selectively inhibiting endocytosis of the BCR on kinase phosphorylation, we left B cells untreated or treated them with dynasore, then incubated them for various lengths of time with Cy5-anti-IgM. We then made them permeable and immunostained them for p-Lyn, p-Syk, p-c-Raf, p-Erk, p-Jnk and p-p38, followed by detection with Alexa Fluor 488-conjugated secondary antibodies and confocal microscopy. Treatment with dynasore resulted in the phosphorylation of both proximal and downstream kinases at the plasma membrane localized together with the BCR (Fig. 6 and Supplementary Figs. 4-6) .
To determine if the phosphorylation of kinases in dynasore-treated cells was quantitatively similar to that in untreated cells, we quantified phosphorylated kinases by immunoblot analysis of lysates of cells left untreated or treated with dynasore for various times after BCR crosslinking ( Fig. 7 and Supplementary Fig. 7 ). In addition, we analyzed by immunoblot the phosphorylation of Akt and the kinase MEK1, as specific antibodies that recognize phosphorylated forms of either protein were not effective for confocal microscopy. In untreated cells, phosphorylation of Syk was maximal as early as measured, at 2 min after BCR crosslinking, and decreased thereafter, which reflected the results of confocal microscopy. In dynasore-treated cells, the temporal pattern of Syk phosphorylation was similar; however, Syk was hyperphosphorylated at all time points. The phosphorylation of MEK1, Erk and p38 in untreated cells also seemed maximal at 2 min after BCR crosslinking, although by confocal microscopy this was first detectable at approximately 5 min. In dynasore-treated cells, the kinases were hyperphosphorylated at each time point, as the Figure 6 The subcellular distribution of phosphorylated kinases in dynasore-treated B cells. Intensity analyses (as in Fig. 1b) of Alexa Fluor 488 (green) and Cy5 (red) in mouse splenic B cells either incubated for 1 h in RPMI medium with DMSO alone or dynasore in DMSO and immediately fixed, made permeable and stained with Cy5-anti-IgM (to detect the BCR) and antibodies specific for p-Lyn, p-c-Raf, or p-Jnk followed by Alexa Fluor 488-conjugated secondary antibodies (far left; 0 min), or incubated for 0.5-60 min (above plots) in RPMI medium with DMSO alone or dynasore in DMSO, with Cy5-anti-IgM, then fixed, made permeable and stained with and antibodies specific for p-Lyn, p-c-Raf, or p-Jnk followed by Alexa Fluor 488-conjugated secondary antibodies (cell images, Supplementary Fig. 4 ). Data are representative of five different experiments with ~80 cells total. To determine if the block in endocytosis of the BCR that resulted in hypophosphorylation of Akt affected downstream targets of Akt, we determined the phosphorylation state of proteins in the Akt signaling pathway. Activated Akt functions to phosphorylate members of the Foxo transcription factor family, whose transcriptional targets include genes that encode proapoptotic and antiproliferative proteins 26 . In dynasore-treated cells, there was much less phosphorylation of Foxo1 and Foxo3a (Fig. 8a) . Phosphorylation of another downstream target of Akt, 4E-BP1 (a component of the mRNA translational machinery) was also lower in dynasore-treated cells.
We next assessed by quantitative PCR array the effect of blocking endocytosis of the BCR on the expression of genes encoding 80 transcription factors, including those downstream of BCR signaling pathways, and 90 genes encoding molecules involved in B cell activation or the Akt pathway. We compared gene expression in cells treated with dynasore alone, anti-IgM alone or dynasore plus anti-IgM with that in untreated cells. We measured transcription 1 h after BCR crosslinking, a window of time in which dynasore was effective in blocking endocytosis and yet still reversible (Fig. 8b,c and Supplementary Data Set) . By analysis of genes that changed at least twofold in their expression, we found that the expression of four genes, Jun and Junb (which encode molecules downstream of Jnk) 27 , Atf4 (which encodes a molecule that interacts with Jun) 28 , and Ets2 and Gtf2b (which encode transcription factors), was significantly higher only in cells treated with the combination of dynasore plus anti-IgM. The expression of Egr1 (which encodes a molecule downstream of Erk) 29 , was higher in cells treated with antiIgM but was even higher in cells treated with dynasore plus anti-IgM. The expression of Atf3 (which encodes a molecule downstream of the Jnk pathway) 28 and Cebpb (which encodes a transcription factor with an important role in regulating lymphoid cell growth and differentiation) 30, 31 was even higher in cells treated with dynasore plus anti-IgM than in cells treated with anti-IgM or dynasore alone. In addition, many genes encoding molecules involved in inflammatory response, such as Nfkbia, Hsp90ab1 and Il10, had significantly higher expression in cells treated with dynasore plus anti-IgM. In contrast, Bcl6, Ptprc, Rgs1 and Klf6 were upregulated and Casp9 and Fasl were downregulated both in cells treated with dynasore alone and cells treated with dynasore plus anti-IgM. Apc (which encodes a molecule involved in regulation of the Akt pathway) was significantly downregulated in cells treated with dynasore plus anti-IgM. Thus, restricting BCR signaling to the plasma membrane both interfered with BCR-mediated kinase phosphorylation and altered the transcription of genes encoding molecules associated with B cell activation.
DISCUSSION
Here we have provided evidence that antigen-induced BCR signaling was initiated at the plasma membrane and continued as the BCR was endocytosed and trafficked intracellularly and that the BCRs activated different kinases in the signaling pathway at different subcellular locations. Treatment of B cells with the dynamin inhibitor dynasore, to block endocytosis of the BCR, resulted in dysregulation of kinase activation and of downstream gene transcription. Thus, the hierarchical subcellular compartmentalization of the BCR seems to serve as a critical regulator of BCR signaling and has a key role in defining the outcome of signaling.
Published studies have provided evidence that interfering with BCR internalization either by depletion of clathrin and actin depolymerization (by genetic means) in DT40 cells expressing wild-type BCR 16 or by substituting the tyrosine residues in the immunoreceptor tyrosine activation motifs of the immunoglobulin β-chain results in dysregulation of signaling 32 . In the former study, Erk was hyperphosphorylated, similar to our observations of wild-type BCRs in spleen B cells; however, in the latter study, activation of Src and Syk was lower but activation of Akt and Erk was prolonged. These differences in results may reflect differences in the signaling capacity of the wildtype BCR 16 and the BCR with the mutant immunoglobulin β-chain 32 . Because discrete signaling and internalization motifs have not been identified in the cytoplasmic domains of immunoglobulin α-chain and β-chain of the BCR, it is not possible to attribute the effect of a mutation exclusively to a signaling versus trafficking function of the BCR. Differences in results of the three studies may also reflect the differences in the degree to which internalization was blocked. In the studies of the wild-type BCR, complete blockade was achieved 16 , and in the studies of the mutant BCR, the blockade was partial 32 . Nonetheless, those published findings established a molecular link between BCR internalization and signaling and suggested that BCR trafficking through endosomes leads to attenuation of signaling. In the context of the results presented here, we would interpret those earlier findings differently and suggest that the observed dysregulated signaling was in part the result of dysregulated internalization that failed to deliver the BCR to the appropriate intracellular site for regulation of activation.
Contrary to the present view that BCR internalization functions to extinguish signaling, our results presented here have shown that proper signaling was achieved only when the BCR was endocytosed into the cell. Notably, constitutively active BCR signaling has been linked to the survival of B cell lymphomas 33 . In B cell lymphomas dependent on the BCR for their survival, BCR internalization is often blocked, which results in more BCRs on the plasma membrane. Our results suggest that plasma membrane retention could account for prolonged but dysregulated BCR signaling that contributes to tumor survival.
An important question raised by the results presented here is as follows: by what mechanisms does subcellular compartmentalization of internalized BCR regulate signaling and downstream gene transcription? We speculate that different endosomal compartments expose BCRs to different arrays of kinases, phosphatases, adaptors or lipid microenvironments. For example, it is possible that the lower phosphorylation of Akt observed when BCR signaling was restricted to the plasma membrane was due to prolonged exposure of Akt to phosphatases that it might not normally encounter intracellularly. Indeed, the phosphatase PHLPP, which directly dephosphorylates Akt and has been shown to regulate Akt activity in regulatory T cells 34 , is also located at the plasma membrane 35 . Through the use of green fluorescent protein-tagged Akt it has been shown that within seconds of BCR crosslinking, Akt is transiently recruited to the plasma membrane for 40-50 s and then is rapidly recycled, regardless of high activity of phosphatidylinositol-(3,4,5)-trisphosphate at the plasma membrane 36 . However, Akt phosphorylation is sustained for at least 1 h, which suggests that although initial activation of Akt requires membrane translocation, full activation is achieved in intracellular compartments. Notably, activation of Akt induced by angiotensin II receptor also requires internalization of the receptor to endosomes positive for early endosomal marker EEA1 (ref. 37 ). We were unable to monitor the spatial distribution of p-Akt, as the available antibodies specific for p-Akt are not suitable for imaging by confocal microscopy or TEM. However, preliminary results with subcellular fractionation by sucrose density fractionation have suggested that p-Akt is present in endosomal compartments.
The intracellular location of the BCR may also be important in providing a platform for the BCR to interact with intracellular receptors. The intracellular TLRs are of particular interest in this. There is mounting evidence that receptors that contain immunoreceptor tyrosine activation motifs regulate TLR signaling 38 , and it is possible that an important feature of such receptor crosstalk is the intracellular proximity of the receptors. Indeed, antigen-induced BCR signaling has been shown to result in the recruitment of TLR9 from small endocytic vesicles to the autophagosome-like compartments into which the BCR traffic 39 . When B cells are provided DNA-containing antigens, such as those that drive autoimmunity, there is enhanced activation of MAPKs, and this signaling occurs in the autophagosome-like compartments to which TLR9 was recruited. It has also been shown that trafficking of both BCRs and TLR9 is disrupted in anergic B cells, which results in sequestration of the BCR and TLR9 outside late endosomes, abrogating TLR9 activation 40 . Although the molecular mechanisms that mediate synergistic signaling remain to be determined, the observations we have reported here (that the BCR activates kinases in discrete subcellular compartments) suggest that the spatial organization of receptors has a key role in determining the nature of their crosstalk. Our studies presented here have provided a new view of antigen-induced signaling by the BCR in which the proper regulation of signaling is dependent on endocytosis of the BCR and the location of the BCR in intracellular compartments. Endosomal signaling by the BCR may provide new therapeutic targets for regulating hyperactivation of the BCR or constitutive BCR activation, such as that in autoimmune diseases and in some B cell cancers.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
